Evidence map›Paper›PMID 23853600›Full record

ArticlePLoS pathogens2013

Irf8-regulated genomic responses drive pathological inflammation during cerebral malaria.

Joanne Berghout, David Langlais, Irena Radovanovic, Mifong Tam, John D MacMicking, Mary M Stevenson, Philippe Gros

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Clonal hematopoiesis and bone marrow inflammation.Translational research : the journal of laboratory and clinical medicine · 2023
    Review
  6. Diagnosis of cerebral malaria: Tools to reduceFrontiers in cellular and infection microbiology · 2023
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Genetic analysis of cerebral malaria in the mouse model infected with Plasmodium berghei.Mammalian genome : official journal of the International Mammalian Genome Society · 2018
    Review
  16. Review
  17. Article
  18. Rocaglates as dual-targeting agents for experimental cerebral malaria.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Joanne BerghoutDepartment of Biochemistry and Complex Traits Group, McGill University, Montreal, Quebec, Canada.
David Langlais
Irena Radovanovic
Mifong Tam
John D MacMicking
Mary M Stevenson
Philippe Gros
McGill University · CAMcGill University Health Centre · CAYale University · US

Funding

NRAMP1 IN MACROPHAGE DEFENCES AGAINST INFECTIONSR01AI035237 · NIAID · MCGILL UNIVERSITY · PI GROS, PHILIPPE · 1993 to 2015
$2.3M
NRAMPL AND PHAGOCYTE FUNCTIONR21AI035237 · NIAID · MCGILL UNIVERSITY · PI GROS, PHILIPPE · 2000 to 2000
$166k
CIHR MOP-79343NIAID NIH HHS AI35237NIAID NIH HHS R01 AI035237NIAID NIH HHS R21 AI035237
6 · The paper itself

Abstract

Interferon Regulatory Factor 8 (IRF8) is required for development, maturation and expression of anti-microbial defenses of myeloid cells. BXH2 mice harbor a severely hypomorphic allele at Irf8 (Irf8(R294C)) that causes susceptibility to infection with intracellular pathogens including Mycobacterium tuberculosis. We report that BXH2 are completely resistant to the development of cerebral malaria (ECM) following Plasmodium berghei ANKA infection. Comparative transcriptional profiling of brain RNA as well as chromatin immunoprecipitation and high-throughput sequencing (ChIP-seq) was used to identify IRF8-regulated genes whose expression is associated with pathological acute neuroinflammation. Genes increased by infection were strongly enriched for IRF8 binding sites, suggesting that IRF8 acts as a transcriptional activator in inflammatory programs. These lists were enriched for myeloid-specific pathways, including interferon responses, antigen presentation and Th1 polarizing cytokines. We show that inactivation of several of these downstream target genes (including the Irf8 transcription partner Irf1) confers protection against ECM. ECM-resistance in Irf8 and Irf1 mutants is associated with impaired myeloid and lymphoid cells function, including production of IL12p40 and IFNγ. We note strong overlap between genes bound and regulated by IRF8 during ECM and genes regulated in the lungs of M. tuberculosis infected mice. This IRF8-dependent network contains several genes recently identified as risk factors in acute and chronic human inflammatory conditions. We report a common core of IRF8-bound genes forming a critical inflammatory host-response network.

Indexed as

Gene Expression RegulationImmunity, InnateAmino Acid SubstitutionAnimalsBinding SitesBrainCells, CulturedCytokinesGene Expression ProfilingInterferon Regulatory Factor-1Interferon Regulatory Factor-8Interferon Regulatory FactorsMalaria, CerebralMiceMice, KnockoutMice, Mutant StrainsCytokinesInterferon Regulatory Factor-1Interferon Regulatory Factor-8Interferon Regulatory FactorsIrf1 protein, mouseMutant ProteinsNerve Tissue Proteins

Identifiers

PMID23853600
PMCPMC3708918
OpenAlexW2006766086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.